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The substantial increase in prevalence and emergence 
of antigenically divergent or highly pathogenic influenza 
A(H7N9) viruses during 2016–17 raises concerns about 
the epizootic potential of these viruses. We investigated 
the evolution and adaptation of H7N9 viruses by analyz-
ing available data and newly generated virus sequences 
isolated in Guangdong Province, China, during 2015–
2017. Phylogenetic analyses showed that circulating 
H7N9 viruses belong to distinct lineages with differing 
spatial distributions. Hemagglutination inhibition assays 
performed on serum samples from patients infected with 
these viruses identified 3 antigenic clusters for 16 strains 
of different virus lineages. We used ancestral sequence 
reconstruction to identify parallel amino acid changes on 
multiple separate lineages. We inferred that mutations in 
hemagglutinin occur primarily at sites involved in recep-
tor recognition or antigenicity. Our results indicate that 
highly pathogenic strains likely emerged from viruses 
circulating in eastern Guangdong Province during March 
2016 and are associated with a high rate of adaptive mo-
lecular evolution.
Since its first detection in March 2013, avian influenza A(H7N9) virus has caused 1,534 human infections 
that, as of November 30, 2017, had resulted in 608 deaths. 
Recurrent waves of human cases have been reported in 27 
provinces in China, indicating sustained transmission of 
H7N9 viruses (1). Moreover, since its emergence, H7N9 
virus has reassorted with influenza A(H9N2) viruses that 
co-circulate in China, resulting in an increasingly diverse 
array of virus genomes (2–4). The fifth influenza epidemic 
wave (2016–17) was marked by a notable increase in the 
number of human cases (677 during September 2016–
May 2017), making it the largest outbreak of influenza 
A(H7N9) since 2013. Moreover, geographic distribution 
of human cases suggests that H7N9 virus is now more 
widespread and that residences of patients have shifted 
gradually from urban to semiurban and rural areas (1,5–
7). These epidemiologic observations have raised public 
health concerns.
Previous molecular surveillance studies suggested that 
H7N9 virus lineages originate in 2 densely populated ar-
eas, the Yangtze River Delta region in eastern China and 
the Pearl River Delta region in central Guangdong Prov-
ince (8). Preliminary epidemiologic data suggested that 
most human infections in the current fifth epidemic wave 
were caused by viruses from the Yangtze River Delta re-
gion (5) (previously named lineage C viruses) (3). These 
viruses, in contrast to viruses from the Pearl River Delta 
region (previously named lineage B viruses) (3), appear 
to exhibit reduced cross-reactivity with existing candidate 
vaccine virus strains (9). Furthermore, a subset of lineage 
C isolates has also acquired a highly pathogenic (HP) phe-
notype (5,10,11).
These observations suggest that the increased epidem-
ic activity of H7N9 viruses in China might be driven, at 
least in part, by ongoing virus evolution and adaptation. 
Decreased cross-reactivity and increased pathogenicity of 
some H7N9 viruses was discovered only recently (9), and 
the genetic diversity and evolution of the current fifth epi-
demic wave of these viruses are not yet well understood. 
Information necessary to clarify this situation includes 
geographic distribution of currently circulating H7N9 virus 
lineages, origin and genetic composition of newly emerged 
HP H7N9 viruses, and evolutionary and structural charac-
terization of mutations associated with the fifth epidemic 
wave of these viruses.
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We report 47 hemaglutinnin (HA) and 43 neuramini-
dase (NA) gene sequences of human-derived and poultry-
derived H7N9 viruses that were isolated during 2015–2017 
in Guangdong Province, China. We conducted structural 
and evolutionary analyses of these strains and character-
ized the evolution and emergence of currently circulating 
H7N9 viruses in China.
Materials and Methods
Ethics
This study was approved by the institutional ethics com-
mittee of the Center for Disease Control and Prevention of 
Guangdong Province. Written consent was obtained from 
patients or their guardian(s) when samples were collected. 
Patients were informed about the study before providing 
written consent, and data were anonymized for analysis.
Sample Collection
Samples from persons with suspected cases of influenza 
A(H7N9) were initially tested for avian influenza A virus 
in provincial clinics in Guangdong Province. Specimens 
with positive results were subsequently analyzed (12,13). 
For poultry-related samples, we obtained samples from 
locations where poultry were housed and processed (e.g., 
cages, feeding troughs, defeathering machines) (12). Re-
spiratory specimens were collected from persons with 
suspected cases of influenza A(H7N9) by the Ministry of 
Health of China.
Sequence Alignment
For phylogenetic studies, we sequenced 47 HA and 41 NA 
sequences from 20 human samples and 28 poultry-related 
samples; all belonged to the fourth and fifth epidemic waves 
of influenza A(H7N9) (GISAID [https://www.gisaid.org/] 
accession nos. EPI866538–77, 972231–6, 972238–303, 
974029, 974523, 974539–42, 997159–60, and 1171786–
93). These new H7N9 sequences were combined with all 
available H7N9 gene sequences whose sampling dates and 
locations were known. Two gene sequence datasets were 
generated: H7, HA (n = 737) and N9, NA (n = 610). We 
constructed multiple sequence alignments by using Clust-
alW (14) and edited these sequences manually by using 
AliView (15).
Molecular Clock Phylogenetic Analysis
We estimated molecular clock phylogenies by us-
ing the Bayesian Markov Chain Monte Carlo approach 
implemented in BEAST version 1.8 (16) as described 
(4). We computed 4 independent Markov Chain Monte 
Carlo runs of 1.5 × 108 steps for each alignment and ex-
tracted a subset of 2,000 phylogenies from the posterior 
tree distribution, subsequently used as an empirical tree 
distribution for phylogeographic analyses (17). We com-
puted maximum clade credibility trees for each dataset by 
using TreeAnnotator (16).
Phylogeographic Analysis of  
Influenza A(H7N9) Epidemic
We used the discrete phylogeographic method (18) imple-
mented in BEAST to investigate spatial dynamics of H7N9 
virus lineages from 6 regions in China as classified in a pre-
vious study (4). The 6 locations were eastern China (Anhui, 
Shanghai, Zhejiang, Jiangsu, and Shandong); central Chi-
na (Jiangxi and Hunan); northern China (Beijing, Henan, 
Hebei, and Xinjiang); southeastern China (Fujian); cen-
tral Guangdong Province (Guangzhou, Huizhou, Foshan, 
Dongguan, Zhongshan, Shenzhen, Jiangmen, Zhaoqing 
Yangjiang, Maoming, and Yunfu); and eastern Guangdong 
Province (Meizhou, Heyuan, Chaozhou, Jieyang, Shantou, 
Shanwei, and Shaoguan).
Because sporadic human cases detected in Malaysia 
and Taiwan were believed to have originated in China, 
we used available epidemiologic information to assign 
their location to the most likely source in China. Hong 
Kong and central Guangdong Province were treated 
as a single location because of their proximity to each 
other. We analyzed reported H7N9 virus infections and 
virus sequences (online Technical Appendix Table 1, 
https://wwwnc.cdc.gov/EID/article/24/10/17-1063-
Techapp1.pdf). To estimate directionality of virus lineage 
movement, we used asymmetric continuous-time Markov 
chain phylogeographic model (19) and a Bayesian sto-
chastic search variable selection procedure (18).
Inferring Phylogenetic Distribution of  
Amino Acid Changes
We investigated phylogenetic positions of amino acid 
changes among H7N9 virus isolates by using HA and NA 
maximum clade credibility trees. We estimated maximum 
posterior probability amino acid sequences for each inter-
nal node by using BEAST with a Jones–Taylor–Thornton 
amino acid substitution model (20), gamma-distributed 
among-site rate heterogeneity (21), and a strict molecular 
clock model. To infer amino acid substitutions along the 
trunk branches of the H7N9 phylogeny, we mapped amino 
acid changes onto internal branches by using a Java script 
(available on request). Trunk branches corresponded to 
internal branches that subtended >5 terminal nodes in the 
fifth influenza epidemic wave.
Structure-Based Mapping Analysis
We used the crystal structure of the HA (Protein Data Bank 
no. 4BSE) (22) and NA (Protein Data Bank no. 2C4L) gly-
coproteins from an influenza A(H7N9) virus to map ami-
no acid changes identified by evolutionary analysis. We 
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performed residue mapping onto the H7 and N9 structures 
by using PyMol (23). We calculated solvent accessibility 
for trimeric hemagglutinin with the ligands removed by us-
ing ESPript (24) and identified receptor-binding residues 
by using CONTACT in CCP4 (25).
Positive Selection Analyses
To identify sites under positive selection, we used methods 
implemented in HyPhy (26) to estimate the dN/dS ratio of 
codons in HA. These methods included single-likelihood 
ancestor counting (27), fixed effects likelihood (27), mixed 
effects model of evolution (28), and the fast unconstrained 
Bayesian approximation approach (29).
Estimating Rates of Virus Molecular Adaptation
We estimated rates of adaptive substitution in H7N9 virus 
HA and NA genes by using an established population genet-
ic method related to the McDonald-Kreitman test (30,31). 
We used a consensus of H7N9 first-wave sequences as an 
outgroup to estimate derived and ancestral mutational site 
frequencies in each subsequent wave. Specifically, we clas-
sified polymorphisms into 3 categories according to their 
frequency in the population (low, 0%–15%; intermediate, 
15%–75%; and high, 75%–100%). We calculated the num-
ber of adaptive substitutions from the number of synony-
mous and nonsynonymous sites in each category and as-
sessed statistical uncertainty by using a bootstrap approach 
(1,000 replicates) (30,31).
Serologic Analysis
We obtained serum samples from 4 patients with influ-
enza A(H7N9) 2–3 weeks after clinical symptoms were 
observed. We performed hemagglutination inhibition 
assays by using different lineages of H7N9 viruses as 
antigens (online Technical Appendix). Three lineage 
C1 strains, 4 lineage C2 strains, 5 lineage B strains, and 
4 HP strains were used as antigens (Table). We calcu-
lated serum titer for each H7N9 strain as the highest 
reciprocal serum dilution providing complete hemagglu-
tination inhibition.
Results
Molecular Epidemiology of Viruses  
Isolated during 2013–2017
During 2013–2017, the influenza A(H7N9) virus epidemic 
lineage was geographically structured and classified into 3 
major lineages, A, B, and C, in accordance with the lin-
eage naming scheme used in a previous study (3). H7N9 
virus has evolved in a clock-like manner (i.e., there is a 
strong linear relationship between genetic divergence and 
sampling time; correlation coefficient 0.95) (Figure 1). The 
estimated time to the most recent common ancestor (TM-
RCA) of H7N9 virus HA sequences is November 2012 
(95% credible region October–December 2012). The corre-
sponding molecular clock phylogeny for NA (online Tech-
nical Appendix Figure 1) also shows A–C lineages and 
has a similar estimated TMRCA of September 2012 (95% 
credible region July–October 2012). However, the topolo-
gy of the NA phylogeny differs from that of HA, suggesting 
reassortment between HA and NA during emergence of the 
H7N9 virus epidemic lineage (Figure 2; online Technical 
Appendix Figure 1).
Different H7N9 virus lineages are associated with dif-
ferent epidemiologic patterns (Figures 2, 3). Specifically, 
most (86%, 32/37) lineage B viruses that were isolated dur-
ing the fourth and fifth influenza epidemic waves descended 
from viruses circulating in central Guangdong Province dur-
ing earlier epidemic seasons (Figure 2). In addition, lineage 
B viruses isolated from the fourth and fifth influenza waves 
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Table. Hemagglutination inhibition titers for serum samples from 4 patients infected with influenza A(H7N9) virus against reference 
H7N9 strains, China* 
H7N9 strain Date of collection Clade 
Titer by patient and H7N9 strain 
P1, strain NA P2, strain NA P3, strain ZS29 P4, strain ST18 
EPI972232/A/CZ009† 2017 Jan C1 2,048 2,048 512 512 
EPI972243/A/MZ011† 2017 Jan C1 4,096 4,096 1,024 512 
EPI1171792/A/ST18† 2017 Jan C1 1,024 512 512 512 
EPI656434/A/ST72 2015 Feb C2 256 128 1024 128 
EPI866569/A/ST021† 2016 Feb C2 256 128 512 128 
EPI656314/A/SW20 2015 Jan C2 256 128 512 128 
EPI1171791/A/SW33† 2015 Feb C2 256 128 512 128 
EPI972259/A/ZS201† 2016 Dec B 256 128 512 128 
EPI972234/A/FS10† 2017 Jan B 256 256 512 128 
EPI656054/A/ZS74 2014 Jan B 512 256 512 128 
EPI656038/A/ZS71 2014 Jan B 256 256 512 128 
EPI656014/A/GZ66 2014 Jan B 512 256 512 64 
EPI1171786/Env/YJ370† 2017 Sep HP 64 64 512 64 
EPI1171788/Env/YJ073† 2017 May HP 64 64 512 64 
EPI1171790/A/ZS29† 2017 Mar HP 128 64 512 64 
EPI919607/A/17SF003 2017 Jan HP 256 64 512 128 
*HP, highly pathogenic; NA, not available; P, patient no. 
†Strains isolated and sequenced in this study. 
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were almost exclusively restricted to central (rather than 
eastern) Guangdong Province (Figures 2, 3). In contrast, 
viruses in eastern China, composed of 2 lineages (A and 
C) have been exported to and become dominant in multiple 
regions as the epidemic has progressed (3). These findings 
indicate a comparatively broader geographic dissemination 
(Figure 3; online Technical Appendix Figure 1).
The new isolates from eastern Guangdong Province, 
combined with isolates from eastern China (1,5), suggest 
that recent H7N9 virus activity is driven primarily by lin-
eage C viruses (Figure 2). The estimated TMRCA of lin-
eage C is December 2013 (95% highest posterior density 
October 2013–January 2014). For lineage C, we observed 2 
clades (Figure 4). The larger of these clades (C1) circulates 
mainly in central and eastern China, and the smaller clade 
(C2) is found predominantly in eastern Guangdong Prov-
ince. Clade C2 also includes recently identified HP viruses 
(Figures 1, 2, 4).
To investigate these HP viruses, we undertook retro-
spective screening of poultry-related samples collected in 
Guangdong Province during January 2016–February 2017 
and identified 7 HP influenza virus isolates that belong 
to the HP cluster within C2 (Figure 2). These HP viruses 
also form a distinct cluster within lineage C viruses in the 
NA phylogeny (online Technical Appendix Figure 1). Our 
analyses indicated that the HP clade likely emerged from 
clade C2 viruses circulating in eastern Guangdong Prov-
ince in 2016.
Adaptive Evolution in Virus C Lineage
We then investigated whether the increasing prevalence of 
lineage C viruses might be associated with virus adapta-
tion. We combined ancestral sequence reconstruction of 
lineage B and C HA gene sequences (Figures 4, 5) by map-
ping residues that have undergone changes onto the crystal 
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Figure 1. Regression of root-to-tip divergence estimated from 
hemagglutinin gene of influenza A(H7N9) viruses, China. Arrow 
indicates the time of the most recent common ancestor of the 
epidemic lineage.
Figure 2. Genetic evolution and spatial spread of epidemic 
lineage of influenza A(H7N9) viruses, China, 2013–2017. 
Bayesian maximum clade credibility tree of the hemagglutinin 
gene is shown. Black bars to the right of the tree indicate 
sequences (from waves 4 and 5) from other studies (1,5), 
and red bars indicate sequences reported in this study from 
Guangdong Province. Branch colors indicate most probable 
ancestral locations of each branch. Three major lineages (A, B, 
and C) of H7N9 viruses were observed. Values along branches 
indicate bootstrap values. Black circles indicate posterior support 
>0.95. Location of posterior support is shown for selected 
clades. An H7N9 strain closely related to the highly pathogenic 
H7N9 virus cluster is indicated. HP, highly pathogenic.
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structure of the trimeric hemagglutinin. Our analysis iden-
tified several notable amino acid substitutions that occurred 
along the internal branches of lineage C viruses (Figure 4).
Around the time of the second influenza epidemic 
wave, ancestral viruses of lineage C acquired several amino 
acid changes in HA, specifically L177I, G386A, S489R, 
and S128N (based on H3 sequence numbering). Three of 
these mutations (G386A, S489R, and S128N) are located 
in solvent-accessible regions of HA (Figure 6; online Tech-
nical Appendix Table 2). Furthermore, S128N was found 
within the 130 loop and is proximal to the receptor surface 
(distance ≈20 Å) (Figure 6).
We found by evolutionary analysis that several HA 
sites acquired amino acid mutations independently in dif-
ferent phylogenetic clades. First, 4 mutations (A135V, 
L177I, M236I, and S489N) occurred independently along 
the trunk lineages that gave rise to the current lineage B 
and C viruses (Figure 5). Three of these mutations (A135V, 
M236I, and S489N) were observed only in the fourth and 
fifth influenza epidemic waves of lineage B (Figure 5). Sec-
ond, comparison of the C1 and C2 clades also identified 
parallel amino acid changes within lineage C (A122T/P 
and M236I) (Figure 4).
The observation of parallel amino acid changes along 
those particular lineages (online Technical Appendix 
Tables 2, 3) that have persisted until the fifth influenza 
epidemic wave (i.e., parallel changes between lineages B 
and C and between the C1 and C2 clades) is suggestive 
of convergent, adaptive molecular evolution. The parallel 
changes in lineage C (A122T/P and M236I) are estimated 
to be fully or partially solvent accessible and the A135V 
mutation is located at the receptor-binding site (Figure 6). 
One subclade of lineage B viruses appears to have acquired 
mutations A135V and S489N within the last 12 months 
(Figure 5). Therefore, we suggest that this subclade should 
be closely monitored in the future.
Within the C2 clade, we found that HA acquired 7 
amino acid changes (I48T, A122P, K173E, L226Q, M236I, 
I326V, and E393K) on the internal branch immediately an-
cestral to the HP cluster. This internal branch represents 
a period of approximately 1 year (Figure 4). Although all 
of these changes appeared in residues with partial or full 
solvent accessibility, mutations K173E, L226Q, and I326V 
are particularly noteworthy because they have arisen at or 
near known antigenic, receptor-binding, and proteolytic 
cleavage sites, respectively (Figure 6). Furthermore, these 
mutations in the HP cluster also coincide with appearance 
of a 4-amino acid insertion (KRTA) near the HA1-HA2 
proteolytic cleavage site (Figure 4). A subset of HA substi-
tutions (at sites 57, 114, 140, 226, and 276) that occurred 
on the trunk branches of lineages B and C viruses was also 
found to be under positive selection on the basis of dN/
dS ratios we estimated by using methods implemented in 
HyPhy (online Technical Appendix Table 4).
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Figure 3. Geographic location 
and lineage classification of 
374 influenza A(H7N9) human 
viruses, China. Values in 
parentheses indicate number 
of sequenced viruses from 
each region. Pie charts indicate 
approximate percentages of 
each virus lineage (A, B, C, or 
unclustered). Sequences from 
Xinjiang Province in northern 
China are not shown.
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We also investigated whether amino acid changes in 
the HA gene during emergence of influenza A(H7N9) vi-
rus have been driven by adaptive evolution similar to that 
observed for seasonal human influenza (30). We found evi-
dence for adaptive evolution in HA genes of B and C virus 
lineages. We estimated that lineage B adapted at a rate of 
0.80 (interquartile range [IQR] 0.21–0.95) adaptive substi-
tutions across the whole HA gene per year and lineage A 
at a rate of 0.60 (IQR 0.10–1.18) adaptive substitutions per 
year. Within lineage C, the estimated adaptation rate of the 
C1 clade is ≈1.84 (IQR 1.09–2.14) adaptive substitutions 
per year and that for the C2 clade (which includes the HP 
cluster) is 3.12 (IQR 2.45–3.79) adaptive substitutions per 
year. These results indicate molecular adaptation across the 
whole H7N9 lineage and suggest that adaptation is faster 
in the 2 C clades than in the A and B lineages. Previous 
estimates of rates of adaptive substitution were 1.02 fixa-
tions per year in the whole HA gene for seasonal human 
influenza A(H1N1) virus and 1.52 fixations per year in the 
whole HA gene for influenza A(H3N2) virus (30). In this 
context, the rate of adaptive evolution observed for lineage 
C here is notable and raises concern for ongoing evolution 
of these viruses.
Antigenic Properties
We collected serum samples from 4 patients infected with 
H7N9 virus during 2015 and 2017 (Table). For patients 3 
and 4, the corresponding virus strains were isolated and 
sequenced. Phylogenetic analysis indicated that patient 3 
was infected with clade C1 virus and that patient 4 was 
infected with HP virus. Hemagglutination inhibition results 
suggested the presence of 3 antigenic clusters among the 16 
H7N9 virus strains selected. Serum samples from patients 
1, 2, and 3 showed similar patterns, reacting robustly to 
clade C1 viruses and moderately to clade C2 and lineage B 
viruses but poorly to HP viruses. A serum sample from a 
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Figure 4. Reconstruction of 
amino acid changes along 
trunk of lineage B phylogenies 
of influenza A(H7N9) viruses, 
China. Maximum clade 
credibility tree of hemagglutinin 
gene sequences from lineage 
B is shown. Branches are 
colored according to geographic 
locations, as in Figure 3. 
Thicker lines indicate the 
trunk lineage leading up to the 
current fifth influenza epidemic 
wave. Amino acid changes 
along the trunk are indicated. 
Red branches indicate sites 
undergoing parallel amino 
acid changes across multiple 
lineages. Mutations correspond 
to H3 numbering scheme. 
*Indicates uncertainty about 
the phylogenetic position of the 
A135V and S128N mutations 
because branch posterior 
support is low.
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patient infected with an HP H7N9 virus appeared to react 
strongly to all H7N9 virus strains.
Discussion
Our results show that H7N9 viruses of lineage C, which 
were prevalent in the recent fifth influenza epidemic wave 
in China, comprise 2 geographically distinct clades (C1 and 
C2) that have undergone adaptive evolution. Clade C1 is 
found primarily in eastern and central China and clade 2 
in Guangdong Province, and both clades appear to have 
circulated in bird populations for ≈3 years. Our ancestral 
state reconstruction analysis provides crucial evidence that 
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Figure 5. Reconstruction of amino 
acid changes along trunk of lineage 
C phylogenies of influenza A(H7N9) 
viruses, China. Maximum clade 
credibility tree of hemagglutinin 
gene sequences from lineage C 
is shown. Branches are colored 
according to geographic locations, 
as in Figure 3. Thicker lines indicate 
the trunk lineage leading up to the 
current fifth influenza epidemic 
wave. Amino acid changes along the 
trunk are indicated. Red branches 
indicate sites undergoing parallel 
amino acid changes across multiple 
lineages. Mutations correspond to 
H3 numbering scheme. *Mutation 
sites not present are numbered 
according to H7 numbering.
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2 successful lineages of H7N9 viruses (lineages B and C) 
have experienced multiple parallel amino acid changes 
(Figures 4, 5), suggesting the possible action of convergent 
molecular evolution.
We also observed a higher rate of virus adaptation in east-
ern Guangdong Province (C2 clade compared with C1). Al-
though clades C1 and C2 are phylogenetically closely related, 
serum from a clade C1 virus-infected patient has moderate 
reactivity with C2 strains from 2015–2016 and poor reactiv-
ity to the HP virus from 2016–2017. The higher adaptation 
rate and antigenic changes in clade C2 are of concern from 
a public health perspective. Introduction of HP avian influ-
enza into domestic poultry might constitute a serious risk, as 
demonstrated by emergence of goose–Guangdong lineage HP 
H5N1 viruses, which spilled back into wild birds and caused 
the longest global outbreak of HP avian influenza to date (33).
Parallel amino acid changes in clades C1 and C2 oc-
curred at 2 sites in HA (122 and 236) (Figure 6). Further-
more, we observed 4 mutations that emerged independently 
in lineages B and C (sites 135, 177, 236, and 489). These re-
sults suggest adaptive convergent molecular evolution. Site 
135 is located in the receptor-binding region and is near 
antigenic site A, as defined by Wiley et al. (34). Thus, the 
observed A135V mutation might modulate receptor affinity 
and contribute to immune escape (Figure 6), as observed in 
influenza A(H7N1) and A(H7N7) viruses (35,36).
Specifically, experimental studies indicate that threo-
nine at position 135 in the HP H7N7 virus A/Netherlands/ 
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Figure 6. Structural analysis of amino acid changes in hemagglutinin in lineages B and C of influenza A(H7N9) viruses, China. Crystal 
structure of the homotrimeric H7 hemagglutinin bound to a human receptor analog (Protein Data Bank no. 4BSE) (27) (A) and rotated 90° 
counterclockwise (B) are shown. Two of the 3 protomers are displayed with high transparency to aid visualization. The carbon Cα positions 
of salient features are shown as spheres. Blue indicates receptor-binding residues, red indicates mutations in lineage B, green indicates 
mutations in lineage C, and orange indicates mutations in lineages B and C. Human receptor analog α2,6-SLN is shown as sticks colored 
according to constituent elements: carbon in orange, oxygen in red, and nitrogen in blue. Dark gray indicates the putative fusion peptide 
(32). Residues are numbered according to the H3 numbering system (online Technical Appendix Table 2, https://wwwnc.cdc.gov/EID/
article/24/10/17-1063-Techapp1.pdf). A135 and L226 participate in receptor binding and thus are likely to modulate receptor specificity.
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219/2003 confers broad-scale resistance to neutralizing 
monoclonal antibodies against the earliest strain of H7N9 
virus (A/Shanghai/02/2013) (37). Furthermore, the World 
Health Organization has reported that recent clade C1 vi-
ruses (but not those of lineage B) react less to postinfec-
tion ferret antiserum raised against the A/Anhui/1/2013 and 
A/Shanghai/2/2013-derived candidate vaccine strains (9). 
Consistent with this finding, we found that most clade C1 
viruses isolated in 2015 have the A135V mutation. How-
ever, this mutation was only detected in a small proportion 
of recent lineage B viruses (Figure 5).
In this study, we performed a preliminary evaluation 
of the antigenicity of H7N9 viruses by using patient se-
rum samples collected in 2015 and 2017. Without serum 
raised in response to early strains from 2013, we cannot 
discriminate antigenic change between strains from 2013 
and those from 2017. However, the limited data we have 
indicate the presence of 3 antigenic clusters among the 
4 phylogenetic clusters circulating during the fifth influ-
enza epidemic wave (Table). HA1 positions 109–301 (H3 
numbering) include the A–E antigenic epitopes, which are 
known to determine antigenicity of influenza A viruses 
(34). The amino acid changes responsible for the anti-
genic differences between clade C1 and other clades were 
located in antigenic site A (position 140, H3 numbering; 
online Technical Appendix Figure 2).
The mutation R140K has been observed in viruses 
isolated from ferrets experimentally infected with avian in-
fluenza A(H7N9) viruses and has been linked to antigenic 
drift of influenza A(H5N1) viruses (38–40). By compar-
ing the sequences of the HP H7N9 virus cluster and other 
clade C2 viruses, we found a substitution in antigenic site E 
(position 173, H3 numbering) that could underlie antigenic 
change in HP H7N9 viruses (online Technical Appendix 
Figure 2). In future work, we aim to explore the roles of 
these substitutions in determining viral antigenicity in the 
context of H7N9 virus genomes by using reverse genetics.
HP H7N9 viruses belonging to lineage C2 were first 
detected in late 2016, but spread greatly in geographic 
range in early 2017 (41). Several mechanisms for the gen-
esis of an HP virus from a low pathogenicity virus have 
been proposed, including transcription errors (42), step-
wise amino acid substitutions (43), or recombination (44). 
For H7, emergence of HP viruses is attributed to nonho-
mologous recombination resulting in simultaneous inser-
tion of several amino acids at the HA cleavage site. These 
insertions might be derived from host 28S rRNA sequence 
(45) or from other influenza gene segments, such as the ma-
trix (46) and nucleoprotein genes (44). The 12-nt insert in 
the HP H7N9 virus strains is 100% identical to a region in 
the polymerase basic 1 gene in multiple avian influenza A 
viruses, including subtypes H3N2, H6N2, and H9N2, but 
is not present in the polymerase basic 1 gene of HP H7N9 
virus. H9N2 virus is the most frequently detected avian in-
fluenza virus in chickens in China, and the detection rate 
of this subtype in environmental samples from live poul-
try markets is ≈20% during the influenza epidemic season 
(13). Therefore, co-infection with H7N9 and other avian 
influenza viruses, such as influenza A(H9N2) viruses, 
could, in theory, lead to insertion of a polybasic cleavage 
site by nonhomologous recombination.
Recent studies have shown that the HP H7N9 virus 
is more pathogenic in mice, and more thermally stable, 
than low pathogenicity A/Anhui/1/2013 virus (47,48). 
Current surveillance indicates that HP H7N9 viruses 
have spread to several provinces in China and are re-
sponsible for large influenza outbreaks in poultry in cen-
tral and northern China that show high mortality rates 
(http://www.fao.org/ag/againfo/programmes/en/empres/
H7N9/situation_update.html). This finding raises the 
possibility of global dissemination of H7N9 viruses 
through migration of wild birds, in a manner similar 
to that observed for HP H5N1 viruses first identified 
in Guangdong Province (32). Although vaccination of 
poultry against H7N9 virus has now been implemented 
in some regions of China, virus adaptation and spatial 
distribution should be more closely monitored.
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